Medway School of Pharmacy
Applications and enquiries
Telephone: +44 (0)1634 202935
Our research programme in Pharmacy gives you the integrated, broad-based research training needed to exploit current advances in pharmaceutical and biological sciences and pharmacy practice.
Within the school we have a number of home, EU and international postgraduate students who are undertaking doctoral research degrees. Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.
About Medway School of Pharmacy
Medway School of Pharmacy is one of the few regional schools of pharmacy in the UK, a collaboration between the University of Kent and the University of Greenwich.
The impetus for the formation of the Medway School of Pharmacy came from the local community, who recognised the shortage of qualified pharmacists in all branches of the pharmacy profession in Kent.
The School is now recognised as an established school with accreditation from the General Pharmaceutical Council (GPhC) and the Health and Care Professions Council (HCPC). Graduates are employed in health disciplines in Kent and the south-east and more broadly across the UK.
In the Research Excellence Framework (REF) 2014, research by the School of Pharmacy was ranked 8th in the UK for research intensity.
An impressive 100% of our research-active staff submitted to the REF and 93% of our research was judged to be of international quality, with 81% of this judged world-leading or internationally excellent. The School’s environment was judged to be conducive to supporting the development of world-leading research.
Duration: 3 to 4 years full-time, 5 to 6 years part-time
Postgraduate students have access to all the facilities at the Medway School of Pharmacy, including clinical skills labs and a ‘simulation man’. As the School of Pharmacy is a joint venture between the two universities, students have access to facilities at Kent’s Medway and Canterbury campuses, and the University of Greenwich.
Dynamic publishing culture
Medway School of Pharmacy has a research culture and as such postgraduate students publish regularly and widely in journals, conference proceedings and books. Among others, they have recently contributed to: International Journal of Pharmacy Practice; Nephron Physiology; Acta Physiologica; Purinergic Signalling; and European Journal of Pharmacology.
Researcher Development Programme
Kent's Graduate School co-ordinates the Researcher Development Programme for research students, which includes workshops focused on research, specialist and transferable skills. The programme is mapped to the national Researcher Development Framework and covers a diverse range of topics, including subject-specific research skills, research management, personal effectiveness, communication skills, networking and teamworking, and career management skills.
Graduates who obtain their PhD from Kent or Greenwich are highly sought after by prospective employers, both within the UK and overseas. Destinations for doctoral graduates include university academic departments, research institutes and leading pharmaceutical and biotechnological companies.
A first or 2.1 honours degree in an appropriate subject and a taught Master’s. Potential applicants with non-standard qualifications but significant experience should contact the School’s Director of Graduate Studies.
General entry requirements
All applicants are considered on an individual basis and additional qualifications, professional qualifications and relevant experience may also be taken into account when considering applications.
Please see our International Student website for entry requirements by country and other relevant information. Due to visa restrictions, students who require a student visa to study cannot study part-time unless undertaking a distance or blended-learning programme with no on-campus provision.
English language entry requirements
The University requires all non-native speakers of English to reach a minimum standard of proficiency in written and spoken English before beginning a postgraduate degree. Certain subjects require a higher level.
For detailed information see our English language requirements web pages.
Need help with English?
Please note that if you are required to meet an English language condition, we offer a number of pre-sessional courses in English for Academic Purposes through Kent International Pathways.
The Medway School of Pharmacy houses strong and vibrant research groups that span a range of pharmacy-related areas. Staff have a wealth of research experience, and UK and international links with both industry and academic institutions.
Chemistry and drug delivery
This group has laboratories with dedicated state-of-the art drug delivery, nanotechnology, spectroscopy, chromatography and organic synthesis facilities. It brings together researchers in medicinal chemistry and drug design, nanotechnology and materials science, drug delivery and pharmaceutics encouraging a multidisciplinary approach to research. Research covers synthesis and biological evaluation of potential anti-cancer agents, structure-based drug design, QSAR predication of ADMET properties, controlled release, particle engineering, powder technology, pharmaceutical technology, and novel drug delivery systems, with a focus on respiratory drug delivery.
This group is housed in recently refurbished laboratories with dedicated state-of-the-art molecular biological, electrophysiological, tissue culture and microscopy facilities. The research is divided into four main themes; infectious diseases and allergy; neuroscience; renal and cardiovascular physiology; and pharmacology. Examples of current work include: investigation of the use of non-pathogenic virus ‘pseudotypes’ to study pathogenic RNA, study of the properties of neuronal potassium channels and their modulation and the development of new therapies for patients that have developed acute kidney injury in collaboration with a major pharmaceutical company.
This group conducts research in two areas: public health and medicines optimisation, with a particular focus on cardiovascular diseases and mental health. Work in public health includes studies in physical exercise, alcohol, cardiovascular screening and spirometry testing, plus pharmacovigilance. Studies in medicines optimisation include work in dementia, bipolar disorder and stroke, with an emphasis on the patient perspective.
Staff research interests
Medway School of Pharmacy has over twenty academic research staff arranged in three primary research groups: Biological Sciences, Chemistry and Drug Delivery and Clinical and Professional Practice. Each of these academics has developed their own research programme.
Full details of staff research interests can be found on the School's website.
The 2022/23 UK fees for this course are:
Pharmacy - PhD - full-time at Medway School of Pharmacy
- Home full-time £TBC
- EU full-time £21200
- International full-time £21200
For students continuing on this programme fees will increase year on year by no more than RPI + 3% in each academic year of study except where regulated.* If you are uncertain about your fee status please contact email@example.com.
Your fee status
The University will assess your fee status as part of the application process. If you are uncertain about your fee status you may wish to seek advice from UKCISA before applying.
General additional costs
Find out more about general additional costs that you may pay when studying at Kent.
Search our scholarships finder for possible funding opportunities. You may find it helpful to look at both:
|Circadian Rhythms and Aging||Dr Gurprit Lall, Dr Aiste Steponenaite|
|Selection and evaluation of new universal influenza vaccine candidates using monoclonal antibodies and digitally designed HA and NA libraries & pseudotype virus screens||Dr Nigel Temperton, Dr Simon Scott , Prof Jonathan Heeney (University of Cambridge)|
|Generation of human cytomegalovirus-pseudotyped particles and development of systems for the study of viral cell entry mechanisms, neutralizing antibody responses to infection and vaccination, and testing of potential novel therapeutics||Dr Simon Scott , Dr Nigel Temperton, Dr Matthew Reeves (UCL)|
|Formulation of layered silicate-polymer composite particles for the potential oral delivery of biologics||Dr Vivek Trivedi, Dr Vadim Sumbayev|
|The Creation of Anti-Viral Plastic Nanobodies for Diagnostics and Therapeutics via Molecular Imprinting of Synthetic Polymers||Dr Andrew J Hall, Dr Nigel Temperton|
|Deciphering the landscape of nucleoporin and lamin function in nucleocytoplasmic communication, nuclear scaffolding and transcriptional control in disease prevention||Dr Fani Papagiannouli, Dr Gurprit Lall|
|Design, Synthesis and Biological Evaluation of Tumour Targeting Analogues of Combretastatin A4||Dr M A Casely-Hayford, Dr N Lavignac, Dr V Sumbayev|
|Cross-modal sensory integration for motor decision making.||Dr Stella Koutsikou, Dr Tobias von der Haar|
|Development of lipid-polymer hybrid nanoparticles via microfluidics, for the intracellular delivery of nucleic acid therapeutics||Dr Nathalie Lavignac, Dr Vladimir Gubala|
|Cross-talks of immune checkpoint pathways determine the abilities of human malignant tumours to suppress cytotoxic attacks and escape immune surveillance||Dr Vadim V Sumbayev|